Literature DB >> 7546416

Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease.

P Brouwers1, G Tudor-Williams, C DeCarli, H A Moss, P L Wolters, L A Civitello, P A Pizzo.   

Abstract

OBJECTIVE: To study the relationships between stage of HIV disease, reflected by CD4+ lymphocyte percentages and p24 antigen levels, and HIV-associated central nervous system (CNS) abnormalities, measured by computed tomography (CT) brain-scan ratings and neurobehavioral tests.
DESIGN: Consecutive case series.
SETTING: Government medical research center. PATIENTS: Eighty-six previously untreated children with symptomatic HIV-1 disease.
RESULTS: CD4% measures correlated significantly with overall CT brain-scan severity ratings (r = -0.45; P < 0.001) as well as with its component parts (cortical atrophy, white matter abnormalities, and intracerebral calcifications); they were of comparable magnitude for vertically and transfusion-infected children. CD4% measures were also associated with the general level of cognitive function (r = 0.32; P < 0.005). Furthermore, patients with detectable serum p24 antigen levels (n = 39) had CT brain scans that were more abnormal than patients with undetectable p24 levels (n = 20; CT abnormality ratings of 21.3 versus 35.9; P < 0.02); similar differences were found for the cortical atrophy and calcification ratings. p24 levels also correlated with the overall CT brain-scan severity rating (r = 0.34; P < 0.01).
CONCLUSIONS: Degree of CT brain-scan abnormality and level of cognitive dysfunction were significantly associated with the stage of HIV-1 disease, as reflected by either CD4 leukocyte measures or elevations of p24 antigen. The relation between the CT brain-scan lesions and markers of HIV disease (both CD4 and p24) suggest that these CNS abnormalities are most likely associated with HIV-1 infection, and further support the hypothesis that the interaction between systemic disease progression and CNS manifestations is continuous rather than discrete.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546416     DOI: 10.1097/00002030-199507000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

1.  Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts.

Authors:  Theodore D Ruel; Michael J Boivin; Hannah E Boal; Paul Bangirana; Edwin Charlebois; Diane V Havlir; Philip J Rosenthal; Grant Dorsey; Jane Achan; Carolyne Akello; Moses R Kamya; Joseph K Wong
Journal:  Clin Infect Dis       Date:  2012-02-04       Impact factor: 9.079

Review 2.  Systematic review of neuroimaging studies in vertically transmitted HIV positive children and adolescents.

Authors:  Jacqueline Hoare; Gabrielle L Ransford; Nicole Phillips; Taryn Amos; Kirsten Donald; Dan J Stein
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

3.  Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children.

Authors:  Laurén A Gómez; Claudia S Crowell; Irene Njuguna; Lisa M Cranmer; Dalton Wamalwa; Daisy Chebet; Vincent Otieno; Elizabeth Maleche-Obimbo; Melissa Gladstone; Grace John-Stewart; Sarah Benki-Nugent
Journal:  Pediatr Infect Dis J       Date:  2018-09       Impact factor: 2.129

Review 4.  Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment.

Authors:  C Exhenry; D Nadal
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

5.  Cognitive and motor deficits associated with HIV-2(287) infection in infant pigtailed macaques: a nonhuman primate model of pediatric neuro-AIDS.

Authors:  J M Worlein; J Leigh; K Larsen; L Kinman; A Schmidt; H Ochs; R J Y Ho
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

6.  Adaptation of an HIV Medication Adherence Intervention for Adolescents and Young Adults.

Authors:  Idia B Thurston; Laura M Bogart; Madeline Wachman; Elizabeth F Closson; Margie R Skeer; Matthew J Mimiaga
Journal:  Cogn Behav Pract       Date:  2014-05

7.  Maturational changes in peripheral lymphocyte subsets pertinent to monitoring human immunodeficiency virus-infected Chinese pediatric patients.

Authors:  K M Kam; W L Leung; K H Wong; S S Lee; M Y Hung; M Y Kwok
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 8.  Neurologic aspects of HIV infection in infants and children: therapeutic approaches and outcome.

Authors:  Lucy Civitello
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

9.  Early immunological predictors of neurodevelopmental outcomes in HIV-infected children.

Authors:  Jutarat Mekmullica; Pim Brouwers; Manhattan Charurat; Mary Paul; William Shearer; Hermann Mendez; Clemente Diaz; Jennifer S Read; Prosanta Mondal; Renee Smith; Kenneth McIntosh
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

10.  Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing.

Authors:  B U Mueller; B D Anderson; M Q Farley; R Murphy; J Zuckerman; P Jarosinski; K Godwin; C L McCully; H Mitsuya; P A Pizzo; F M Balis
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.